Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Jul;44(7):1980-2.
doi: 10.1128/AAC.44.7.1980-1982.2000.

Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas

C M Bebear  1 , H Renaudin, A Bryskier, C Bebear
Affiliations
Comparative Study

Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas

C M Bebear et al. Antimicrob Agents Chemother. 2000 Jul.

Abstract

The activities of telithromycin and levofloxacin against 99 mycoplasma strains were compared to those of several macrolides, ofloxacin, and doxycycline. Telithromycin MICs of </=0.25 microgram/ml were found for all isolates, except for Mycoplasma hominis, while levofloxacin was active at concentrations of </=1 microgram/ml against all species studied.

PubMed Disclaimer

References

    1. Bébéar C, Robertson J. Determination of minimal inhibitory concentration. In: Tully J G, Razin S, editors. Molecular and diagnostic procedures in mycoplasmology. II. San Diego, Calif: Academic Press, Inc.; 1996. pp. 189–199.
    1. Bébéar C M, Renaudin H, Aydin M D, Chantot J F, Bébéar C. In-vitro activity of ketolides against mycoplasmas. J Antimicrob Chemother. 1997;39:669–670. - PubMed
    1. Bébéar C M, Renaudin H, Boudjadja A, Bébéar C. In vitro activity of BAY 12-8039, a new fluoroquinolone, against mycoplasmas. Antimicrob Agents Chemother. 1998;42:703–704. - PMC - PubMed
    1. Bébéar C M, Renaudin H, Schaeverbeke T, Leblanc F, Bébéar C. In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas. J Antimicrob Chemother. 1999;43:711–714. - PubMed
    1. Bébéar C M, Renaudin J, Charron A, Renaudin H, de Barbeyrac B, Schaeverbeke T, Bébéar C. Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob Agents Chemother. 1999;43:954–956. - PMC - PubMed

Publication types